Does a Nanomolecule of Carboplatin Injected Periocularly Help in Attaining Higher Intravitreal Concentrations?SHOME, Debraj; PODDAR, Neha; HONAVAR, Santosh et al.Investigative ophthalmology & visual science. 2009, Vol 50, Num 12, pp 5896-5900, issn 0146-0404, 5 p.Article

Relationship between cisplatin administration and the development of ototoxicityRADEMAKER-LAKHAI, Jeany M; CRUL, Mirjam; ZUUR, Lot et al.Journal of clinical oncology. 2006, Vol 24, Num 6, pp 918-924, issn 0732-183X, 7 p.Article

A column-switching liquid chromatography assay for the analysis of carboplatin in plasma ultrafiltratALLSOPP, M. A; SEWELL, G. J; ROWLAND, C. G et al.Journal of pharmaceutical and biomedical analysis. 1992, Vol 10, Num 5, pp 375-381, issn 0731-7085Article

Allergic reactions to carboplatinHENDRICK, A. M; SIMMONS, D; CANTWELL, B. M. J et al.Annals of oncology. 1992, Vol 3, Num 3, pp 239-240, issn 0923-7534Article

Factors for Hematopoietic Toxicity of Carboplatin: Refining the Targeting of Carboplatin Systemic ExposureSCHMITT, Antonin; GLADIEFF, Laurence; PINGUET, Frédéric et al.Journal of clinical oncology. 2010, Vol 28, Num 30, pp 4568-4574, issn 0732-183X, 7 p.Article

Oxaliplatin-induced immune pancytopeniaTALEGHANI, Behrouz Mansouri; FONTANA, Stefano; MEYER, Oliver et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 5, pp 704-708, issn 0041-1132, 5 p.Article

CisplatinMEENAKSHI DABHOLKAR; CHRISTIAN, M; REED, E et al.Cancer chemotherapy and biological response modifiers annual. 1994, Vol 15, pp 87-98, issn 0921-4410Article

General pharmacology of cis-malonato [(4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3-dioxalone]platinum(II)KIM, D.-K; AHN, J. S; RUY, G et al.Arzneimittel-Forschung. 1994, Vol 44, Num 9, pp 1080-1088, issn 0004-4172Article

Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine WastingLANCASTER, Cynthia S; CHAOXIN HU; FRANKE, Ryan M et al.Clinical cancer research (Print). 2010, Vol 16, Num 19, pp 4789-4799, issn 1078-0432, 11 p.Article

Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorptionARNDT, Patricia; GARRATTY, George; ISAAK, Edahn et al.Transfusion (Philadelphia, PA). 2009, Vol 49, Num 4, pp 711-718, issn 0041-1132, 8 p.Article

Modulation of cis-diamminedichloroplatinum(II) resistance : a reviewTIMMER-BOSSCHA, H; MULDER, N. H; DE VRIES, E. G. E et al.British journal of cancer. 1992, Vol 66, Num 2, pp 227-238, issn 0007-0920Article

CisplatinREED, E.Cancer chemotherapy and biological response modifiers annual. 1992, Vol 13, pp 83-90, issn 0921-4410Article

The interaction of platinum complexes with DNA studied by differential scanning calorimetryNUNOMURA, K; MAEDA, Y; OHTSUBO, E et al.Journal of General and Applied Microbiology. 1991, Vol 37, Num 2, pp 207-214, issn 0022-1260Article

A note on the solution chemistry of carboplatin in aqueous solutionsLEDERER, M; LEIPZIG-PAGANI, E.International journal of pharmaceutics. 1998, Vol 167, Num 1-2, pp 223-228, issn 0378-5173Article

Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposureLEE, Suh-Young; KANG, Hye-Ryun; SONG, Woo-Jung et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 1021-1029, issn 0344-5704, 9 p.Article

Overestimation of carboplatin doses is avoided by radionuclide GFR measurementCRAIG, A. J; SAMOL, J; HEENAN, S. D et al.British journal of cancer. 2012, Vol 107, Num 8, pp 1310-1316, issn 0007-0920, 7 p.Article

Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approachHYUK NAM KWON; KIM, Mina; HONG, Soon-Sun et al.Kidney international. 2011, Vol 79, Num 5, pp 529-537, issn 0085-2538, 9 p.Article

Implication des canaux ioniques dans l'hypersensibilité au froid induite par l'oxaliplatine = Oxaliplatin-induced cold hypersensitivity is due to remodeling of ion channels in nociceptorsDESCOEUR, Juliette; PEREIRA, Vanessa; LAZDUNSKI, Michel et al.Cancéro digest. 2011, Vol 3, Num 3, pp 215-217, issn 1953-5171, 3 p.Article

Amelioration of Oxaliplatin Neurotoxicity by Drugs in Humans and Experimental Animals: A MiniReview of Recent LiteratureALI, Badreldin H.Basic & clinical pharmacology & toxicology (Print). 2010, Vol 106, Num 4, pp 272-279, issn 1742-7835, 8 p.Article

Lung Adjuvant Cisplatin Evaluation : A Pooled Analysis by the LACE Collaborative GroupPIGNON, Jean-Pierre; TRIBODET, Hélène; SPIRO, Stephen G et al.Journal of clinical oncology. 2008, Vol 26, Num 21, pp 3552-3559, issn 0732-183X, 8 p.Article

Cervical radiculopathy due to intra-arterial infusion of cisplatinNISHIMURA, Toshiro; SANADA, Jun-Ichiro; FURUKAWA, Mitsuru et al.Journal of laryngology and otology. 2005, Vol 119, Num 8, pp 649-650, issn 0022-2151, 2 p.Article

Cellular potassium ion deprivation enhances apoptosis induced by cisplatinMARKLUND, Linda; ANDERSSON, Britta; BEHNAM-MOTLAGH, Parviz et al.Basic & clinical pharmacology & toxicology (Print). 2004, Vol 94, Num 5, pp 245-251, issn 1742-7835, 7 p.Article

Quantification of Pt bound to DNA using total-reflection X-ray fluorescence (TXRF)FERNANDEZ RUIZ, R; TORNERO, J. D; GONZALEZ, V. M et al.Analyst (London. 1877. Print). 1999, Vol 124, Num 4, pp 583-585, issn 0003-2654Article

Current issues in chemotherapy: The taxanes, platinum compounds, and oxazaphosphorinesKEARNS, Christine M.Pharmacotherapy. 1997, Vol 17, Num 5, issn 0277-0008, 68 p., 2Conference Proceedings

Carboplastin dosing based on measurement of renal function : experience at the Peter MacCallum Cancer InstituteMILLWARD, M. J; WEBSTER, L. K; TONER, G. C et al.Australian and New Zealand journal of medicine. 1996, Vol 26, Num 3, pp 372-379, issn 0004-8291Article